Not finding it? Sign in to also search OpenAlex live.
-
Step-in Dosing in the Bosutinib Dose Optimization Study (BODO) Failed to Reduce Gastrointestinal (GI) Toxicity in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) but Suggests Promising Molecular Response
Susanne Isfort, Dominik Georg Friedrich Wolf, Lino Lars Teichmann, Martina Margrit Crysandt, Andreas Burchert, Andreas Hochhaus, +11 more
5citations -
Phase transitions in the spin- 1 2 Heisenberg antiferromagnet on the dimerized diamond lattice2025 Physical review. B./Physical review. B article Physics and Astronomy Advanced Condensed Matter Physics Open access
Ronja Bärwolf, Alexander Sushchyev, Francesco Parisen Toldin, Stefan Weßel
2citations -
Local laser-induced solid-phase recrystallization of phosphorus-implanted Si/SiGe heterostructures for contacts below 4.2 K2024 Physical Review Materials article Physics and Astronomy Semiconductor materials and interfaces Open access
Malte Neul, Isabelle V. Sprave, Laura K. Diebel, Lukas G. Zinkl, Florian Fuchs, Yuji Yamamoto, +3 more
8citations -
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study
Valentina DE GIORGIS, Kailash P. Bhatia, Odile Boespflug‐Tanguy, Domitille Gras, Adela Della Marina, Archana Desurkar, +10 more
15citations -
Sleep disturbances in the prodromal phase of mood episodes in patients with bipolar disorder: a replicated single-case design2025 Journal for Person-Oriented Research article Medicine Bipolar Disorder and Treatment Open access
Stefan E. Knapen, Evelien Snippe, Arnout Christiaan Smit, Robert A. Schoevers, Rixt F. Riemersma‐van der Lek
1citations -
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study
Kirsten Müller‐Vahl, Anna Pisarenko, Natalia Szejko, Martina Haas, Carolin Fremer, Ewgeni Jakubovski, +9 more
39citations -
Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
George K.K. Lau, Bruno Sangro, Oxana Crysler, Wattana Sukeepaisarnjaroen, Oleg Nikolaevich Lipatov, Manabu Morimoto, +12 more
8citations -
Phase 1 Trial of Darigabat for the Reduction of Acute Psychological and Physiological Panic and Fear Symptoms Following CO2 Inhalation in Healthy Participants (S8.005)2023 Neurology article Psychology Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Rachel Gurrell, Ih Chang, Ann Dandurand, Sridhar Duvvuri, Amy Guigliano, Gina M. Pastino, +7 more
2citations -
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Hartmut Goldschmidt, Eva Nievergall, Roland R. Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, +25 more
33citations -
Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial
Simon Parkinson Bach, David Sebag‐Montefiore, Victoria Homer, Alexandra Gilbert, Ane Lindegaard Appelt, Ian Geh, +94 more
0citations -
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders2021 International Journal of Molecular Sciences article Medicine Alzheimer's disease research and treatments Open access
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld
22citations -
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial2022 The Lancet Diabetes & Endocrinology article Medicine Thyroid Disorders and Treatments Open access
Marie‐Louise van der Hoorn, Ole Bjarne Christiansen, Madelon van Wely
95citations -
MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Artak Labadzhyan, Susan Leanne Samson, Lisa B. Nachtigall, Maria Fleseriu, William Henry Ludlam, H Patou, +7 more
0citations -
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations